Outcomes of Treatment With Combination Topical 5-Fluorouracil 5.0%/Calcipotriene 0.005% Cream in Patients With Cutaneous In Situ Squamous Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Combination topical 5-fluorouracil 5%/calcipotriene 0.005% cream for the treatment of cutaneous in situ squamous cell carcinoma: a pilot study
J Am Acad Dermatol 2024 Aug 24;[EPub Ahead of Print], RT Patel, KK Fagan, EY Quan, NM Johnson, AN Tegge, AC Holliday, DJ Grider, PS Rush, KA Prickett, JD Eikenberg, MA PhillipsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.